InflaRx NV (IFRX)
1.17
-0.07
(-5.65%)
USD |
NASDAQ |
Nov 13, 16:00
1.17
0.00 (0.00%)
After-Hours: 19:59
InflaRx Enterprise Value : 52.58M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 52.58M |
| November 11, 2026 | 43.73M |
| November 10, 2026 | 48.15M |
| November 09, 2026 | 62.89M |
| November 06, 2026 | 62.15M |
| November 05, 2026 | 69.52M |
| November 04, 2026 | 87.94M |
| November 03, 2026 | 108.58M |
| November 02, 2026 | 129.94M |
| October 30, 2026 | 114.47M |
| October 29, 2026 | 122.58M |
| October 28, 2026 | 124.79M |
| October 27, 2026 | 114.47M |
| October 26, 2026 | 101.94M |
| October 23, 2026 | 99.73M |
| October 22, 2026 | 95.31M |
| October 21, 2026 | 98.26M |
| October 20, 2026 | 96.79M |
| October 19, 2026 | 83.52M |
| October 16, 2026 | 64.37M |
| October 15, 2026 | 82.05M |
| October 14, 2026 | 87.94M |
| October 13, 2026 | 98.26M |
| October 12, 2026 | 104.15M |
| October 09, 2026 | 105.63M |
| Date | Value |
|---|---|
| October 08, 2026 | 95.31M |
| October 07, 2026 | 99.73M |
| October 06, 2026 | 102.68M |
| October 05, 2026 | 117.42M |
| October 02, 2026 | 123.31M |
| October 01, 2026 | 121.84M |
| September 30, 2026 | 135.10M |
| September 29, 2026 | 92.35M |
| September 28, 2026 | 87.93M |
| September 25, 2026 | 98.25M |
| September 24, 2026 | 104.14M |
| September 23, 2026 | 108.56M |
| September 22, 2026 | 126.25M |
| September 21, 2026 | 132.14M |
| September 18, 2026 | 127.72M |
| September 17, 2026 | 123.30M |
| September 16, 2026 | 120.35M |
| September 15, 2026 | 117.41M |
| September 14, 2026 | 132.14M |
| September 11, 2026 | 127.72M |
| September 10, 2026 | 121.83M |
| September 09, 2026 | 127.72M |
| September 08, 2026 | 139.51M |
| September 04, 2026 | 146.88M |
| September 03, 2026 | 148.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MediGene AG | -- |
| BioNTech SE | 5.828B |
| Immatics NV | 510.09M |
| Oncolytics Biotech, Inc. | 42.70M |
| Sangamo Therapeutics, Inc. | 37.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.807M |
| Total Expenses (Quarterly) | 2.807M |
| EPS Diluted (Quarterly) | -0.0191 |
| Earnings Yield | -36.44% |
| Normalized Earnings Yield | -29.90 |